News

ICYMI | Grassley’s Leadership Recognized Multiple Times During Commerce Committee Hearing On Prescription Drug Pricing Reform WASHINGTON...

A U.S. Senate panel grilled secretive pharmacy benefit managers in a hearing Thursday on how to bring fairness and transparency to U.S....

Several bipartisan senators are clamoring for more transparency into how pharmacy benefit managers conduct their business, potentially...

Our responsibility as a leader in the healthcare system is to bring forward actionable ideas, data and insights to help create a...

The celebrity investor has teamed up with a soft-spoken radiologist to tackle the USA’s healthcare crisis – and he has drug industry...

The rising cost of health care is a sore point for all consumers and nowhere is it more glaring than at the pharmacy counter. However,...

UnitedHealth Group Inc. was accused by Louisiana’s attorney general of inflating prescription drug charges in the state’s Medicaid...

The prices that private insurers agree to pay hospitals for cancer drugs are often at least double what the hospital paid to acquire the...

U.S. Sen. Raphael Warnock just introduced a bill that would cap Americans’ out-of-pocket spending on insulin at $35 a month. The...

The Federal Trade Commission recently requested public comments on the effect of drug-industry middlemen on drug affordability and...

With its landscape focus on reducing the excess burden of disease in vulnerable populations, the Biden administration has clearly renewed...

“Among other provisions, this bill would direct the Federal Trade Commission (FTC) to launch a study and report to Congress on the...

U.S. Sen. Ron Wyden (D-OR) is urging the Centers for Medicare and Medicaid Services (CMS) to finalize the proposal that applies all...

Too many people go to the pharmacy counter only to be told the cost of their prescription medicine has gone up. Again. It’s maddening at...

The Federal Trade Commission could help shed light on the complex practices of pharmacy liaisons that have long faced criticism for...

Following the Federal Trade Commission’s decision to not, at least initially, dig deeper into pharma middlemen known as PBMs, the...

Pharmacy benefit managers — liaisons between pharmaceutical companies and health insurers that run patients’ prescription benefits — are...

The request for information comes on the heels of the FTC's failed bid to launch a formal inquiry into PBM practices that would have...

In the last 4 years, the three biggest pharmacy benefit managers have consolidated influence in the U.S. health care marketplace through...

New Report from the Community Oncology Alliance studies "How PBMs Adversely Impact Cancer Care While Profiting at the Expense of...